Absence Seizures: Clinical Trials

5 trials for Absence Seizures, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Completed 1

Follow Absence Seizures: new trials by email Literature Review of Absence Seizures trials Research Report on Absence Seizures

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessing Comorbidities in Epilepsy Using Eye Movement Recordings
Childhood Absence Epilepsy, Absence Seizures
CompletedEysz, Inc.602024-04-152025-10-15
Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings
Eysz Hyperventilation Recorder - Absence Epilepsy, Childhood, Absence Seizures
CompletedEysz, Inc.652023-12-012025-10-15
Detecting Absence Seizures Using Eye Tracking
Eye movement analysis - Epilepsy, Generalized, Absence Epilepsy
CompletedRachel Kuperman1502020-07-152022-07-05
ECV - Epihunter Clinical Validation
Epihunter - Absence Seizures, Absence Epilepsy
Not applicableCompletedEpihunter NV1022020-05-012022-04-04
A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures
Levetiracetam - Absence Seizures
Phase 2CompletedUCB Pharma42000-05-012013-09-17

Narrower conditions

Seizures (5)  ·  Epilepsy, Absence (4)  ·  Epilepsy (1)  ·  Epilepsy, Generalized (1)  ·  Hyperventilation (1)

Broader conditions

Nervous System Diseases (5)  ·  Neurologic Manifestations (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Epileptic Syndromes (4)  ·  Epilepsy (3)  ·  Epilepsy, Generalized (3)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)  ·  Signs and Symptoms, Respiratory (1)

Interventions

Eye-Tracking Technology (1)  ·  Levetiracetam (1)

Sponsors

Eysz, Inc. (2)  ·  Epihunter NV (1)  ·  Rachel Kuperman (1)  ·  UCB Pharma (1)

Countries

United States (4)  ·  Belgium (1)  ·  Denmark (1)  ·  Georgia (1)

Top investigators

Dirk Loeckx, PhD (1)  ·  Rachel Kuperman, MD (1)

NIH funding

R43NS129363 (1)